With a market capitalization of $18,847,592, NeuroMetrix Inc has a greater market value than only 5.5% of US stocks.
Revenue growth over the past 12 months for NeuroMetrix Inc comes in at -35.59%, a number that bests merely 9.22% of the US stocks we're tracking.
NeuroMetrix Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -22.07%, greater than the shareholder yield of merely 12.1% of stocks in our set.
If you're looking for stocks that are quantitatively similar to NeuroMetrix Inc, a group of peers worth examining would be XONE, HTGM, SRTS, SONM, and ULBI.
NeuroMetrix Inc. is a medical device company that designs, develops and sells proprietary products used to diagnose neuropathies. The Company's neuropathy diagnostic system provides primary care and specialist physicians objective information that aids in the diagnosis of neuropathies at the point of service.
Increasing launch of wearable medical devices is expected to propel growth of Asia Pacific smart medical devices market over the forecast period. For instance, in January 2020, VivaLNK, a China-based provider of connected healthcare solutions for in-patient and remote patient
WOBURN, Mass., Jan. 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2020 fourth quarter and full year financial results before the opening of the market on January 28, 2021. The Company will host a conference call at 8:00 a.m., Eastern Time on January 28, 2021 to discuss its financial results as well as business developments affecting the Company. The conference call may be accessed in the United States by dialing 844-787-0799 and using the confirmation code 8694435. Internationally, the conference call may be accessed by dialing 661-378-9630 and using the same confirmation code. The earnings press release and accompanying condensed financial statements will be accessible from the Company's website at www.NeuroMetrix.com under the...
Global Internet-of-Medical-Things Market Report from AMA Research highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, players market shares, and strategies that are key in the market. The exploration
This report provides in-depth study on the current state of the Global Diabetic Neuropathy Market 2020-2025. Key players in the Global Diabetic Neuropathy Market have been identified through the secondary research and their market share has been determined through primary